Mechanism & formula
Oral rehydration therapy: the simplest formula that saved the most lives
Water, salt, and a little sugar — mixed from a packet, administered without needles, cheap enough to deploy anywhere on earth. Oral rehydration therapy is one of the great low-technology advances in medicine. Understanding it is prerequisite to understanding why an absorption-focused electrolyte drink is built the way it is.
Diarrheal disease once killed by the millions — and plain water was not the answer
Before the mid-twentieth century, severe diarrheal dehydration from cholera killed in hours. The gut stopped absorbing fluid and started secreting it. Patients lost liters. Drinking plain water, or even salt water, was not enough to keep pace.
Cholera is caused by Vibrio cholerae, a bacterium that colonizes the small intestine and secretes a toxin — cholera toxin. The toxin drives a sustained rise in cyclic AMP inside the gut cells, which forces their chloride channels open. Chloride floods into the intestinal lumen; sodium and water follow by osmosis. In severe cases a patient can lose more than a litre of fluid per hour as watery stool. Collapse and death from hypovolemic shock can follow within hours of symptom onset.
Intravenous rehydration could replace that loss, but it required needles, sterile equipment, trained personnel, and cold-chain infrastructure. In epidemic cholera — particularly in South and Southeast Asia — most affected populations had none of those things. The gap between what IV therapy could provide and what was actually available was the gap between life and death for enormous numbers of people. Researchers in the 1950s and 1960s were not asking how to improve IV fluid. They were asking whether the gut itself, given the right solution, could absorb enough, fast enough, to replace an IV line entirely.
cents
the cost of a single oral rehydration salts sachet — on the order of US$0.10, cheaper than almost any medicine
>1 L/hr
fluid loss rate in severe cholera — the scale of what ORT had to overcome
2002
WHO reduced-osmolarity revision — when evidence showed lower was better
How a laboratory discovery reached a refugee camp in a decade
From the first mechanistic proposal to field proof to global standardization, the ORT story moved faster than almost any comparable public-health advance. Each step depended on the one before.
Early 1960s — The cotransport hypothesis
Physiologist Robert Crane proposes that sodium and glucose cross the intestinal wall together through a single carrier. If true, the implication is immediate: adding glucose to a salt solution should dramatically accelerate sodium absorption. The hypothesis is contested but begins to gather experimental support through the mid-1960s, with independent work from groups including Schultz and Zalusky confirming active co-absorption in animal intestine.
1968 — First clinical trials
Researchers at the Cholera Research Laboratory in Dhaka (now icddr,b) and at Johns Hopkins publish early clinical evidence that oral glucose-electrolyte solutions can maintain or restore fluid balance in adult cholera patients. The results are promising but the patient populations are relatively stable; the most extreme cases still receive IV support.
1971 — Bangladesh refugee crisis: proof under fire
The Bangladesh Liberation War generates one of the largest refugee flows of the twentieth century. Cholera spreads through border camps in West Bengal where IV supplies run out almost immediately. A team led by the physician Dilip Mahalanabis, working at a camp near Bangaon, turns to oral rehydration solution under crisis conditions and documents case-fatality far below what untreated cholera would produce — approaching the results of IV therapy in well-resourced settings. The camps are the field trial. The conditions are catastrophic. The result holds, and it moves oral rehydration from promising clinical finding to proven public-health tool.
1978 — The Lancet assessment
An unsigned editorial in The Lancet draws a now-famous judgment: that the discovery linking sodium and glucose transport in the gut — the science underpinning oral rehydration — was potentially the most important medical advance of the century. The assessment travels. It is paraphrased throughout public-health literature, in UNICEF reports and WHO policy documents — and it is still cited because the underlying claim has held up under scrutiny.
2002 — WHO reduced-osmolarity revision
Cochrane-reviewed evidence shows that the original WHO formulation (311 mOsm/L) could be improved. A lower-osmolarity solution — sodium 75 mmol/L, glucose 75 mmol/L, total osmolarity 245 mOsm/L — absorbs more effectively and reduces unscheduled IV interventions in children with acute diarrhea. The WHO revises its global standard downward. Less, in this formulation, absorbs better. It is among the cleanest examples in medicine of an evidence-based downward revision of a working standard.
A 1978 editorial in The Lancet assessed the discovery that sodium and glucose transport are coupled in the small intestine — so that glucose accelerates the absorption of solute and water — as potentially the most important medical advance of the century.— paraphrased from an unsigned editorial, The Lancet, 5 August 1978
What we are, and what we are not
Oral rehydration therapy
- A WHO/UNICEF clinical intervention for pathological fluid loss.
- Studied in patients with active cholera, dysentery, and acute diarrheal illness.
- Indicated for managing dehydration from disease.
- Sodium 75 mmol/L, glucose 75 mmol/L in the current reduced-osmolarity standard.
- Distributed through health systems and emergency relief programs.
Just Electrolyte Quick Rehydrate
- An absorption-optimized hydration product for healthy adults.
- No disease claim. Not a treatment. Not medicine.
- Borrows the same cotransport principle — sodium plus a functional dose of glucose, dosed to the mechanism.
- ~4 g/L dextrose (~2.4 g per bottle): enough to engage SGLT1, not a gram more.
- The heritage is the science. The science is not the claim.
ORT is medicine. We are not. What we borrow is the absorption science — the same cotransport mechanism, the same principle that a functional dose of glucose accelerates sodium uptake, the same logic that osmolarity matters and that less can absorb better than more. That science is not proprietary to the clinical formulation. It is basic physiology, and it applies whenever a drink is trying to move sodium across a gut lining efficiently.
Citing ORT is not a claim to be ORT. It is a claim that the absorption science behind our formula is not new, not invented for marketing purposes, and not in dispute. It has been tested in the hardest conditions in the world for more than fifty years. That is the heritage. The drink is the application.
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Sources
- Water with sugar and salt [unsigned editorial]. The Lancet 1978 Aug 5;2(8084):300–301 (PMID 79090). (Some databases index this issue under the continuous volume number 312.)
- Munos MK, Fischer Walker CL, Black RE. The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality. International Journal of Epidemiology 39(Suppl 1):i75–i87, 2010.
- Hahn S, Kim Y, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database of Systematic Reviews 2002, Issue 1, CD002847.
- WHO/UNICEF. Reduced osmolarity ORS (sodium 75 mmol/L, glucose 75 mmol/L, total 245 mOsm/L), adopted 2002, revised down from the earlier 311 mOsm/L standard.
- UNICEF Supply Division — oral rehydration salts (per-sachet cost on the order of US$0.10).
Dosed to the mechanism
Every number on this page appears again on the label, per format. The science hub maps the rest of the picture.